Keep an eye on this cancer-treatment-related biotech with earnings growth
Keep an eye on this cancer-treatment-related biotech with earnings growth.
$DCPH
Its industry is beautifully strengthening. Today Biotech is among the top 20% of industries and also among the top 20% of accelerating industries.
It has earnings growth (though the EPS is still negative, which is not uncommon in small biotechs). It has a short squeeze potential.
Technicals are interesting (see more later on that) and you may watch to see if the daily has a bullish close above the white Direction line. Weekly has a very robust Memory trendline support. The daily is interesting. The sharp up-move a few days ago was associated with earnings. That day had BigMoveUp3 very bullish momentum. Then it pulled back right to the Memory support and now going up. The last two days closed with an upper tail. That was expected as the overall market was dropping sharply. This stock managed to elk out small gains for both of the last two days. Watch for a bullish close today without an upper tail. That will show bulls are in firm control.
Will you consider buying this stock? How will you like to actually enter the trade? Using real-time intraday chart (Precsion Entry chart) during the day or at the close of the day? Or wait for tomorrow's open?
#CUE has specific guidelines for each of those entry techniques.